Qingbo Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Qingbo Xu has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Yanhua Hu
10 shared publications- Manuel Mayr
Imperial College London
8 shared publications Fergus Davison
Department of Cardiac and Vascular Sciences, St George’s Hospital Medical School, London, United Kingdom. 2Division of Cardiology, Department of Internal Medicine, University Hospital, Innsbruck, Austria
4 shared publicationsMichael Leitges
4 shared publicationsUrsula Mayr
4 shared publicationsBernhard Metzler
3 shared publications
Latest Publications
- 1 July 2006
- Published by Elsevier in Kidney International
- Vol. 70 (2) , 315-320
Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model
- 1 July 2006
- Published by Elsevier in Kidney International
- Vol. 70 (2) , 315-320
Characterization of neointima lesions associated with arteriovenous fistulas in a mouse model
- 1 February 2006
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 3 (2) , 94-101
The impact of progenitor cells in atherosclerosis
The integrity of the endothelium can be damaged in various ways, making the formation of atherosclerotic lesions possible. The source of cells involved in endothelial repair and smooth-muscle accumulation in lesions has been debated, but data suggest progenitor cells as a likely origin. Their role in the pathogenesis of atherosclerosis is discussed here. During the pathogenesis of arteriosclerosis, endothelial cells on the arterial wall damaged by various means were initially thought to be replaced by replication of neighboring cells. Smooth-muscle cells (SMCs) were also thought to migrate from the media into the intima, where they constituted arteriosclerotic lesions. This concept has been challenged, however, by the discovery that progenitor cells in the circulation and adventitia contribute to endothelial repair and SMC accumulation. Studies have demonstrated that atherosclerosis is a pathophysiologic process initiated by endothelial death in specific areas, such as bifurcation regions, and with subsequent replacement by endothelial progenitor cells. Differentiation of the neoendothelial cells into mature endothelium takes several days or weeks, during which LDL deposits in the intima. Blood mononuclear cells also adhere to neoendothelial cells and migrate into the subendothelial space. Meanwhile, progenitor cells from blood and the adventitia migrate into the intima, where they proliferate and differentiate into neo-SMCs. All risk factors for atherosclerosis can exert their effects on the vessel wall partly via increase in endothelial turnover, inhibition of progenitor-cell differentiation, and promotion of smooth-muscle and macrophage accumulation in lesions. Thus, progenitor cells comprise the main cell source responsible for the formation of atherosclerotic lesions, which appear in the context of inflammatory disease. Here I provide an update on research and discuss the role of progenitor cells in the pathogenesis of atherosclerosis.
- 1 February 2006
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 3 (2) , 94-101
The impact of progenitor cells in atherosclerosis
The integrity of the endothelium can be damaged in various ways, making the formation of atherosclerotic lesions possible. The source of cells involved in endothelial repair and smooth-muscle accumulation in lesions has been debated, but data suggest progenitor cells as a likely origin. Their role in the pathogenesis of atherosclerosis is discussed here. During the pathogenesis of arteriosclerosis, endothelial cells on the arterial wall damaged by various means were initially thought to be replaced by replication of neighboring cells. Smooth-muscle cells (SMCs) were also thought to migrate from the media into the intima, where they constituted arteriosclerotic lesions. This concept has been challenged, however, by the discovery that progenitor cells in the circulation and adventitia contribute to endothelial repair and SMC accumulation. Studies have demonstrated that atherosclerosis is a pathophysiologic process initiated by endothelial death in specific areas, such as bifurcation regions, and with subsequent replacement by endothelial progenitor cells. Differentiation of the neoendothelial cells into mature endothelium takes several days or weeks, during which LDL deposits in the intima. Blood mononuclear cells also adhere to neoendothelial cells and migrate into the subendothelial space. Meanwhile, progenitor cells from blood and the adventitia migrate into the intima, where they proliferate and differentiate into neo-SMCs. All risk factors for atherosclerosis can exert their effects on the vessel wall partly via increase in endothelial turnover, inhibition of progenitor-cell differentiation, and promotion of smooth-muscle and macrophage accumulation in lesions. Thus, progenitor cells comprise the main cell source responsible for the formation of atherosclerotic lesions, which appear in the context of inflammatory disease. Here I provide an update on research and discuss the role of progenitor cells in the pathogenesis of atherosclerosis.
- 1 December 2005
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (12) , 2571-2576
Association of Serum-Soluble Heat Shock Protein 60 With Carotid Atherosclerosis
Background and Purpose— Previous work has shown that soluble heat shock protein 60 (HSP60; sHSP60), present in circulating blood, is associated with carotid atherosclerosis. In the current evaluation, we tested the hypothesis that sHSP60 levels are associated with the progression of carotid arteriosclerosis, prospectively. Methods— The association of sHSP60 with early atherogenesis (5-year development and progression of nonstenotic carotid plaques) was investigated as part of the population-based prospective Bruneck Study. The current study focused on the follow-up period between 1995 and 2000 and, thus, included 684 subjects. Results— sHSP60 levels measured in 1995 and 2000 were highly correlated ( r =0.40; P P =0.003 after adjustment for age and sex). HSP60 levels were significantly associated with early atherogenesis, both in the entire population (multivariate odds ratio, for a comparison between quintile group V versus I+II: 2.0 [1.2 to 3.5] and the subgroup free of atherosclerosis at the 1995 baseline: 3.8 [1.6 to 8.9]). The risk of early atherogenesis was additionally amplified when high-sHSP60 and chronic infection were present together. Conclusions— Our study provides the first prospective data confirming an association between high levels of sHSP60 and early carotid atherosclerosis. This possibly indicates an involvement of sHSP60 in activating proinflammatory processes associated with early vessel pathology.
- 1 December 2005
- Published by Wolters Kluwer Health in Stroke
- Vol. 36 (12) , 2571-2576
Association of Serum-Soluble Heat Shock Protein 60 With Carotid Atherosclerosis
Background and Purpose— Previous work has shown that soluble heat shock protein 60 (HSP60; sHSP60), present in circulating blood, is associated with carotid atherosclerosis. In the current evaluation, we tested the hypothesis that sHSP60 levels are associated with the progression of carotid arteriosclerosis, prospectively. Methods— The association of sHSP60 with early atherogenesis (5-year development and progression of nonstenotic carotid plaques) was investigated as part of the population-based prospective Bruneck Study. The current study focused on the follow-up period between 1995 and 2000 and, thus, included 684 subjects. Results— sHSP60 levels measured in 1995 and 2000 were highly correlated ( r =0.40; P P =0.003 after adjustment for age and sex). HSP60 levels were significantly associated with early atherogenesis, both in the entire population (multivariate odds ratio, for a comparison between quintile group V versus I+II: 2.0 [1.2 to 3.5] and the subgroup free of atherosclerosis at the 1995 baseline: 3.8 [1.6 to 8.9]). The risk of early atherogenesis was additionally amplified when high-sHSP60 and chronic infection were present together. Conclusions— Our study provides the first prospective data confirming an association between high levels of sHSP60 and early carotid atherosclerosis. This possibly indicates an involvement of sHSP60 in activating proinflammatory processes associated with early vessel pathology.
- 23 August 2005
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (8) , 1206-1213
Anti–Heat Shock Protein 60 Autoantibodies Induce Atherosclerosis in Apolipoprotein E–Deficient Mice via Endothelial Damage
Background— Accumulating evidence established a positive association of anti–heat shock protein 60 (HSP60) autoantibodies and the presence of atherosclerosis in humans. However, whether these autoantibodies play a causal role in the development of atherosclerosis is unknown. Methods and Results— In the present study, anti-HSP60 autoantibodies from blood of patients with coronary heart disease were isolated by affinity chromatography and injected into the tail vein of apolipoprotein E–deficient mice. Atherosclerotic lesions in aortas were significantly increased 8 weeks after injection. Furthermore, administration of a specific mouse monoclonal antibody (II-13) recognizing amino acid residues 288 to 366 of HSP60 effectively induced atherosclerotic lesions in apolipoprotein E–deficient mice. II-13 injection resulted in endothelial cell damage, followed by increased leukocyte attachment and accumulation of macrophages and smooth muscle cells in lesions. Interestingly, II-13–induced atherosclerosis was blocked by pretreatment of animals with F(ab) 2 segments derived from the antibody, but not mouse IgG F(ab) 2. . Conclusions— Autoantibodies recognizing amino acid residues 288 to 366 of HSP60 induce atherosclerosis via the mechanisms of autoimmune reactions to HSP60 expressed on arterial endothelial cells, which can be prevented by F(ab) 2 segments derived from these antibodies.
- 23 August 2005
- Published by Wolters Kluwer Health in Circulation
- Vol. 112 (8) , 1206-1213
Anti–Heat Shock Protein 60 Autoantibodies Induce Atherosclerosis in Apolipoprotein E–Deficient Mice via Endothelial Damage
Background— Accumulating evidence established a positive association of anti–heat shock protein 60 (HSP60) autoantibodies and the presence of atherosclerosis in humans. However, whether these autoantibodies play a causal role in the development of atherosclerosis is unknown. Methods and Results— In the present study, anti-HSP60 autoantibodies from blood of patients with coronary heart disease were isolated by affinity chromatography and injected into the tail vein of apolipoprotein E–deficient mice. Atherosclerotic lesions in aortas were significantly increased 8 weeks after injection. Furthermore, administration of a specific mouse monoclonal antibody (II-13) recognizing amino acid residues 288 to 366 of HSP60 effectively induced atherosclerotic lesions in apolipoprotein E–deficient mice. II-13 injection resulted in endothelial cell damage, followed by increased leukocyte attachment and accumulation of macrophages and smooth muscle cells in lesions. Interestingly, II-13–induced atherosclerosis was blocked by pretreatment of animals with F(ab) 2 segments derived from the antibody, but not mouse IgG F(ab) 2. . Conclusions— Autoantibodies recognizing amino acid residues 288 to 366 of HSP60 induce atherosclerosis via the mechanisms of autoimmune reactions to HSP60 expressed on arterial endothelial cells, which can be prevented by F(ab) 2 segments derived from these antibodies.
- Open Access
- 1 June 2005
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (6) , H2946-H2954
Biomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-κB signaling pathways
IL-6, a proinflammatory cytokine, has been implicated in the development of vascular diseases. We previously demonstrated that mechanical stress can initiate signaling pathways leading to smooth muscle cell (SMC) proliferation and apoptosis, but little is known concerning cyclic stress-induced inflammatory response. To explore the role of stretch in the upregulation of cytokine expression in SMCs we performed RNase protection assay for a panel of cytokines and found that mechanical stress resulted in a time-dependent induction of IL-6 mRNA but not other cytokines, e.g., IL-1α, IL-1β, IL-6, IL-10, IL-12p35, IL-12p40, IL-18, IFN-γ, and macrophage migration inhibitory factor (MIF). This induction also correlated with elevated IL-6 protein levels in the supernatant. Pretreatment of the cells with NF-κB inhibitors inhibited NF-κB activity and resulted in marked inhibition (50%) of IL-6 protein. Moreover, SMC lines stably expressing dominant-negative Ras (RasN17) or Rac (RacN17) exhibited a remarkable decrease in p38 MAPK activity and IL-6 mRNA induction by mechanical stress. Furthermore, a significant inhibition of 30 and 40% in IL-6 protein was observed in SMCs pretreated with inhibitors of p38 MAPK and ERK1/2, respectively, but not JNK. Interestingly, SMCs isolated from PKC-δ-deficient mice exhibited higher levels of IL-6 compared with wild-type cells. Finally, high levels of IL-6 expression were observed in atherosclerotic lesions of vein bypass grafts, which are related to altered biomechanical stress. Our findings demonstrate that biomechanical stress-induced IL-6 expression occurs via a mechanism that involves Ras/Rac/p38 MAPK/NF-κB/NF-IL6 signaling pathways, which is downregulated by PKC-δ, and suggest that modulation of this event contributes to the pathogenesis of atherosclerosis.
- 1 June 2005
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 288 (6) , H2946-H2954
Open AccessBiomechanical stress induces IL-6 expression in smooth muscle cells via Ras/Rac1-p38 MAPK-NF-κB signaling pathways
IL-6, a proinflammatory cytokine, has been implicated in the development of vascular diseases. We previously demonstrated that mechanical stress can initiate signaling pathways leading to smooth muscle cell (SMC) proliferation and apoptosis, but little is known concerning cyclic stress-induced inflammatory response. To explore the role of stretch in the upregulation of cytokine expression in SMCs we performed RNase protection assay for a panel of cytokines and found that mechanical stress resulted in a time-dependent induction of IL-6 mRNA but not other cytokines, e.g., IL-1α, IL-1β, IL-6, IL-10, IL-12p35, IL-12p40, IL-18, IFN-γ, and macrophage migration inhibitory factor (MIF). This induction also correlated with elevated IL-6 protein levels in the supernatant. Pretreatment of the cells with NF-κB inhibitors inhibited NF-κB activity and resulted in marked inhibition (50%) of IL-6 protein. Moreover, SMC lines stably expressing dominant-negative Ras (RasN17) or Rac (RacN17) exhibited a remarkable decrease in p38 MAPK activity and IL-6 mRNA induction by mechanical stress. Furthermore, a significant inhibition of 30 and 40% in IL-6 protein was observed in SMCs pretreated with inhibitors of p38 MAPK and ERK1/2, respectively, but not JNK. Interestingly, SMCs isolated from PKC-δ-deficient mice exhibited higher levels of IL-6 compared with wild-type cells. Finally, high levels of IL-6 expression were observed in atherosclerotic lesions of vein bypass grafts, which are related to altered biomechanical stress. Our findings demonstrate that biomechanical stress-induced IL-6 expression occurs via a mechanism that involves Ras/Rac/p38 MAPK/NF-κB/NF-IL6 signaling pathways, which is downregulated by PKC-δ, and suggest that modulation of this event contributes to the pathogenesis of atherosclerosis.
- 25 February 2005
- Vol. 57 (1) , 1-6
Endothelial progenitor cells in angiogenesis.
Circulating blood contains a subtype of progenitor cells that have the capacity to differentiate into mature endothelial cells in vitro and in vivo. These cells have been termed endothelial progenitor cells (EPCs). The isolation of EPCs by adherence culture or magnetic microbeads has been described. EPCs are characterized by the expression of 3 markers, CD133, CD34, and the vascular endothelial growth factor receptor-2. After differentiation, EPCs express CD31, vascular endothelial cadherin, and von Willebrand factor. Evidence is accumulating that EPCs can facilitate endothelial repair and angiogenesis in vivo. We observed that EPCs can regenerate damaged endothelial cells in vascular grafts in apoE-deficient mice, and that abundant vascular progenitor cells are present in the adventitia of the vessel wall. It is not clear yet, however, whether these EPCs are essential for these angiogenic and atherogenic processes. Moreover, there are still many uncertainties about how cardiovascular risk factors alter EPC function. Thus, further studies on the mechanisms of EPC homing, releasing and attaching will be of help to explore areas of potential basic research and clinical application of EPCs.
- 25 February 2005
- Vol. 57 (1) , 1-6
Endothelial progenitor cells in angiogenesis.
Circulating blood contains a subtype of progenitor cells that have the capacity to differentiate into mature endothelial cells in vitro and in vivo. These cells have been termed endothelial progenitor cells (EPCs). The isolation of EPCs by adherence culture or magnetic microbeads has been described. EPCs are characterized by the expression of 3 markers, CD133, CD34, and the vascular endothelial growth factor receptor-2. After differentiation, EPCs express CD31, vascular endothelial cadherin, and von Willebrand factor. Evidence is accumulating that EPCs can facilitate endothelial repair and angiogenesis in vivo. We observed that EPCs can regenerate damaged endothelial cells in vascular grafts in apoE-deficient mice, and that abundant vascular progenitor cells are present in the adventitia of the vessel wall. It is not clear yet, however, whether these EPCs are essential for these angiogenic and atherogenic processes. Moreover, there are still many uncertainties about how cardiovascular risk factors alter EPC function. Thus, further studies on the mechanisms of EPC homing, releasing and attaching will be of help to explore areas of potential basic research and clinical application of EPCs.
- Open Access
- 1 August 2004
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (2) , H937-H945
Loss of PKC-δ alters cardiac metabolism
PKC-δ is believed to play an essential role in cardiomyocyte growth. In the present study, we investigated the effect of PKC-δ on cardiac metabolism using PKC-δ knockout mice generated in our laboratories. Proteomic analysis of heart protein extracts revealed profound changes in enzymes related to energy metabolism: certain isoforms of glycolytic enzymes, e.g., lactate dehydrogenase and pyruvate kinase, were absent or decreased, whereas several enzymes involved in lipid metabolism, e.g., phosphorylated isoforms of acyl-CoA dehydrogenases, showed a marked increase in PKC-δ−/− hearts. Moreover, PKC-δ deficiency was associated with changes in antioxidants, namely, 1-Cys peroxiredoxin and selenium-binding protein 1, and posttranslational modifications of chaperones involved in cytoskeleton regulation, such as heat shock protein (HSP)20, HSP27, and the ζ-subunit of the cytosolic chaperone containing the T-complex polypeptide 1. High-resolution NMR analysis of cardiac metabolites confirmed a significant decrease in the ratio of glycolytic end products (alanine + lactate) to end products of lipid metabolism (acetate) in PKC-δ−/− hearts. Taken together, our data demonstrate that loss of PKC-δ causes a shift from glucose to lipid metabolism in murine hearts, and we provide a detailed description of the enzymatic changes on a proteomic level. The consequences of these metabolic alterations on sensitivity to myocardial ischemia are further explored in the accompanyingpaper ([20][1]). [1]: #ref-20
- 1 August 2004
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (2) , H937-H945
Open AccessLoss of PKC-δ alters cardiac metabolism
PKC-δ is believed to play an essential role in cardiomyocyte growth. In the present study, we investigated the effect of PKC-δ on cardiac metabolism using PKC-δ knockout mice generated in our laboratories. Proteomic analysis of heart protein extracts revealed profound changes in enzymes related to energy metabolism: certain isoforms of glycolytic enzymes, e.g., lactate dehydrogenase and pyruvate kinase, were absent or decreased, whereas several enzymes involved in lipid metabolism, e.g., phosphorylated isoforms of acyl-CoA dehydrogenases, showed a marked increase in PKC-δ−/− hearts. Moreover, PKC-δ deficiency was associated with changes in antioxidants, namely, 1-Cys peroxiredoxin and selenium-binding protein 1, and posttranslational modifications of chaperones involved in cytoskeleton regulation, such as heat shock protein (HSP)20, HSP27, and the ζ-subunit of the cytosolic chaperone containing the T-complex polypeptide 1. High-resolution NMR analysis of cardiac metabolites confirmed a significant decrease in the ratio of glycolytic end products (alanine + lactate) to end products of lipid metabolism (acetate) in PKC-δ−/− hearts. Taken together, our data demonstrate that loss of PKC-δ causes a shift from glucose to lipid metabolism in murine hearts, and we provide a detailed description of the enzymatic changes on a proteomic level. The consequences of these metabolic alterations on sensitivity to myocardial ischemia are further explored in the accompanyingpaper ([20][1]). [1]: #ref-20
- 1 August 2004
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (2) , H946-H956
Ischemic preconditioning exaggerates cardiac damage in PKC-δ null mice
Ischemic preconditioning confers cardiac protection during subsequent ischemia-reperfusion, in which protein kinase C (PKC) is believed to play an essential role, but controversial data exist concerning the PKC-δ isoform. In an accompanying study (26), we described metabolic changes in PKC-δ knockout mice. We now wanted to explore their effect on early preconditioning. Both PKC-δ−/− and PKC-δ+/+ mice underwent three cycles of 5-min left descending artery occlusion/5-min reperfusion, followed by 30-min occlusion and 2-h reperfusion. Unexpectedly, preconditioning exaggerated ischemia-reperfusion injury in PKC-δ−/− mice. Whereas ischemic preconditioning increased superoxide anion production in PKC-δ+/+ hearts, no increase in reactive oxygen species was observed in PKC-δ−/− hearts. Proteomic analysis of preconditioned PKC-δ+/+ hearts revealed profound changes in enzymes related to energy metabolism, e.g., NADH dehydrogenase and ATP synthase, with partial fragmentation of these mitochondrial enzymes and of the E2 component of the pyruvate dehydrogenase complex. Interestingly, fragmentation of mitochondrial enzymes was not observed in PKC-δ−/− hearts. High-resolution NMR analysis of cardiac metabolites demonstrated a similar rise of phosphocreatine in PKC-δ+/+ and PKC-δ−/− hearts, but the preconditioning-induced increase in phosphocholine, alanine, carnitine, and glycine was restricted to PKC-δ+/+ hearts, whereas lactate concentrations were higher in PKC-δ−/− hearts. Taken together, our results suggest that reactive oxygen species generated during ischemic preconditioning might alter mitochondrial metabolism by oxidizing key mitochondrial enzymes and that metabolic adaptation to preconditioning is impaired in PKC-δ−/− hearts.
- 1 August 2004
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 287 (2) , H946-H956
Ischemic preconditioning exaggerates cardiac damage in PKC-δ null mice
Ischemic preconditioning confers cardiac protection during subsequent ischemia-reperfusion, in which protein kinase C (PKC) is believed to play an essential role, but controversial data exist concerning the PKC-δ isoform. In an accompanying study (26), we described metabolic changes in PKC-δ knockout mice. We now wanted to explore their effect on early preconditioning. Both PKC-δ−/− and PKC-δ+/+ mice underwent three cycles of 5-min left descending artery occlusion/5-min reperfusion, followed by 30-min occlusion and 2-h reperfusion. Unexpectedly, preconditioning exaggerated ischemia-reperfusion injury in PKC-δ−/− mice. Whereas ischemic preconditioning increased superoxide anion production in PKC-δ+/+ hearts, no increase in reactive oxygen species was observed in PKC-δ−/− hearts. Proteomic analysis of preconditioned PKC-δ+/+ hearts revealed profound changes in enzymes related to energy metabolism, e.g., NADH dehydrogenase and ATP synthase, with partial fragmentation of these mitochondrial enzymes and of the E2 component of the pyruvate dehydrogenase complex. Interestingly, fragmentation of mitochondrial enzymes was not observed in PKC-δ−/− hearts. High-resolution NMR analysis of cardiac metabolites demonstrated a similar rise of phosphocreatine in PKC-δ+/+ and PKC-δ−/− hearts, but the preconditioning-induced increase in phosphocholine, alanine, carnitine, and glycine was restricted to PKC-δ+/+ hearts, whereas lactate concentrations were higher in PKC-δ−/− hearts. Taken together, our results suggest that reactive oxygen species generated during ischemic preconditioning might alter mitochondrial metabolism by oxidizing key mitochondrial enzymes and that metabolic adaptation to preconditioning is impaired in PKC-δ−/− hearts.
- 1 July 2004
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (1) , 1-10
Mouse Models of Arteriosclerosis
- 1 July 2004
- Published by Elsevier in The American Journal of Pathology
- Vol. 165 (1) , 1-10
Mouse Models of Arteriosclerosis
- 1 May 2004
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 113 (9) , 1258-1265
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice
Recent evidence indicates that vascular progenitor cells may be the source of smooth muscle cells (SMCs) that accumulate in atherosclerotic lesions, but the origin of these progenitor cells is unknown. To explore the possibility of vascular progenitor cells existing in adults, a variety of tissues from ApoE-deficient mice were extensively examined. Immunohistochemical staining revealed that the adventitia in aortic roots harbored large numbers of cells having stem cell markers, e.g., Sca-1+ (21%), c-kit+ (9%), CD34+ (15%), and Flk1+ cells (4%), but not SSEA-1+ embryonic stem cells. Explanted cultures of adventitial tissues using stem cell medium displayed a heterogeneous outgrowth, for example, islands of round-shaped cells surrounded by fibroblast-like cell monolayers. Isolated Sca-1+ cells were able to differentiate into SMCs in response to PDGF-BB stimulation in vitro. When Sca-1+ cells carrying the LacZ gene were transferred to the adventitial side of vein grafts in ApoE-deficient mice, β-gal+ cells were found in atherosclerotic lesions of the intima, and these cells enhanced the development of the lesions. Thus, a large population of vascular progenitor cells existing in the adventitia can differentiate into SMCs that contribute to atherosclerosis. Our findings indicate that ex vivo expansion of these progenitor cells may have implications for cellular, genetic, and tissue engineering approaches to vascular disease.
- 1 May 2004
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 113 (9) , 1258-1265
Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice
Recent evidence indicates that vascular progenitor cells may be the source of smooth muscle cells (SMCs) that accumulate in atherosclerotic lesions, but the origin of these progenitor cells is unknown. To explore the possibility of vascular progenitor cells existing in adults, a variety of tissues from ApoE-deficient mice were extensively examined. Immunohistochemical staining revealed that the adventitia in aortic roots harbored large numbers of cells having stem cell markers, e.g., Sca-1+ (21%), c-kit+ (9%), CD34+ (15%), and Flk1+ cells (4%), but not SSEA-1+ embryonic stem cells. Explanted cultures of adventitial tissues using stem cell medium displayed a heterogeneous outgrowth, for example, islands of round-shaped cells surrounded by fibroblast-like cell monolayers. Isolated Sca-1+ cells were able to differentiate into SMCs in response to PDGF-BB stimulation in vitro. When Sca-1+ cells carrying the LacZ gene were transferred to the adventitial side of vein grafts in ApoE-deficient mice, β-gal+ cells were found in atherosclerotic lesions of the intima, and these cells enhanced the development of the lesions. Thus, a large population of vascular progenitor cells existing in the adventitia can differentiate into SMCs that contribute to atherosclerosis. Our findings indicate that ex vivo expansion of these progenitor cells may have implications for cellular, genetic, and tissue engineering approaches to vascular disease.